Hepatocellular Carcinoma

Present invention concerns a kit and an in vitro method, for evaluating a biological stage of an HCC tumour in an individual, based on a sample from the individual, comprising: deriving from the sample a profile data set, the profile data set on a the gene expression panel with the markers CCNG2, EGLN3, EROlL, FGF21, MATlA, RCLl and WDR45L or a substantially similar marker, being a quantitative measure of the amount of a distinct RNA or protein constituent in the panel so that measurement of the constituents enables evaluation of the biological condition or the biological behaviour HCC tumours.

Patents:
WO 2,010,127,417

Inventor(s): DAEMEN ANNELEEN [BE]; DE MOOR BART [BE]; GEVAERT OLIVIER [BE]; LIBBRECHT LOUIS [BE]; VAN MALENSTEIN HANNAH [BE]; VAN PELT JOS [B

Type of Offer: Sale



« More Biotech Patents

---